Mupadolimab, a new antibody, is attracting increasing interest within the research field due to its distinct mechanism of activity. This CD73-blocking compound selectively targets CD73, an cell-surface enzyme https://bookmarklinking.com/story11718814/a-novel-antibody-an-potential-anti-cd73-molecule-reveals-promise